Industrial partners
IDT Biologika
Together with the company IDT Biologika, the DZIF is developing a vaccine against the MERS coronavirus in a consortium of scientists and clinicians.
The company IDT Biologika developed its own cell line for the production of the vaccine on a larger scale.